✦ LIBER ✦

PK-Directed Intravenous Busulfan in Combination with High-Dose Melphalan and Bortezomib As Conditioning Regimen for Patients with Multiple Myeloma

✍ Scribed by Barta, Stefan Klaus; Mazumder, Amitabha; Carter, Jason; Almanzar, Lawrence; Elkind, Richard; Battini, Ramakrishna; Derman, Olga; Kornblum, Noah; Xue, Xiaonan; Verma, Amit; Braunschweig, Ira

Book ID: 122298302
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 176 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.146

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of high-dose melphalan and b

Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

✍ Toshihiro Miyamoto, Goichi Yoshimoto… 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 253 KB

Safety and Efficacy From Intravenous Bus

Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation

✍ Ratanatharathorn, Voravit; Stadtmauer, Edward A.; Yeh, Rosa F.; Freytes, Cesar O 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 93 KB

High-dose melphalan versus busulfan, cyc

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Comparison of high-dose melphalan with a

Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma

✍ Athanasios Anagnostopoulos; Ana Aleman; Gregory Ayers; Michele Donato; Richard C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract ## BACKGROUND High‐dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) as part of the initial treatment regimen improves progression‐free survival (PFS) and overall survival (OS) for patients with multiple myeloma. The optimal preparative regimen for patients with

Intravenous Busulfan and Melphalan as a

Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach

✍ Blanes, Margarita; Lahuerta, Juan J.; González, José D.; Ribas, Paz; Solano, Car 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Busulfan and Cyclophosphamide has Simila

Busulfan and Cyclophosphamide has Similar Outcomes to High Dose Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation In Patients With Multiple Myeloma

✍ A. Mahindra; B. Bolwell; L. Rybicki; R. Dean; B. Pohlman; R. Sobecks; S. Andrese 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB